Amoéba confirms field efficacy of its substance against grapevine downy mildew

In France, Amoéba, producer of a biological biocide, still in the testing phase, capable of eliminating bacterial risk in water and human wounds, and a bio-control product for plant protection, announced an efficacy of its amoeba lysate Willaertia magna C2c Maky in the field against grapevine downy mildew.

The intermediate results of the 13 field trials conducted since May 2019 confirm the efficacy of Willaertia magna magna C2c Maky amoeba lysate in the field against downy mildew on grapevine (Plasmopara viticola).

These tests will be used to prepare the regulatory dossier for the active substance at European level. At this stage of registration, the efficacy of the active substance against at least one of the target species and a crop for which authorisation will be requested must be demonstrated.

Amoéba recalls that the marketing authorisation for the plant protection product(s) containing the active substance could take place in 2022 in the United States and 2025 in Europe, provided that they meet the approval criteria.